GNPX
Genprex IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.00M
P/E Ratio
—
EPS
$-5.06
Beta
-0.96
52W High
$55.00
52W Low
$0.62
50-Day MA
$0.94
200-Day MA
$4.21
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Genprex Inc
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-15.51M |
| Operating Margin | 0.00% |
| Return on Equity | -160.80% |
| Return on Assets | -76.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.87 |
| Price-to-Book | 0.41 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.18 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $10.93M |
| Float | $10.56M |
| % Insiders | 0.97% |
| % Institutions | 0.99% |
Historical Volatility
HV 10-Day
51.51%
HV 20-Day
48.18%
HV 30-Day
47.95%
HV 60-Day
69.65%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026